TY  - GEN
AU  - Anderson,Simon G
AU  - Hutchings,David C
AU  - Woodward,Mark
AU  - Rahimi,Kazem
AU  - Rutter,Martin K
AU  - Kirby,Mike
AU  - Hackett,Geoff
AU  - Trafford,Andrew W
AU  - Heald,Adrian H
TI  - Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
SN  - 1468-201X
PY  - 2017///0717
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - Cause of Death
KW  - Chi-Square Distribution
KW  - Databases, Factual
KW  - Diabetes Mellitus, Type 2
KW  - Electronic Health Records
KW  - England
KW  - epidemiology
KW  - Erectile Dysfunction
KW  - General Practice
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Linear Models
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Myocardial Infarction
KW  - Phosphodiesterase 5 Inhibitors
KW  - therapeutic use
KW  - Protective Factors
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/heartjnl-2015-309223
ER  -